Cite

HARVARD Citation

    Tselikas, L. et al. (2022). Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients. European journal of cancer. pp. 1-12. [Online]. 
  
Back to record